EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Leveraging mass detection to simultaneously quantify surfactant content and degradation mode for highly concentrated biopharmaceuticals

Robert Kopf, Christoph Paschen, Lavinia Müller, Berk Kocar, Martin Wolfring, Mathilde Vincent, Denis Klemm, Christian Bell, Cosimo Pinto

Journal of Pharmaceutical and Biomedical Analysis · 2023

DOI: 10.1016/j.jpba.2023.115651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2023. Verfasst von Robert Kopf und 8 weiteren Autor:innen. Beteiligte Einrichtung: F. Hoffmann-La Roche AG, Grenzacherstrasse 24, CH-4070 Basel, Switzerland. Electronic address: robert.kopf@roche.com. Hauptthemen laut MEDLINE: Surface-Active Agents, Biological Products. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kite Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-ionic surfactants are commonly used in parenteral protein formulations and include polysorbate 20, polysorbate 80 and poloxamer188. Recently, quantification and characterization of surfactants has generated considerable interest due to their connection to visible particle formation, a critical quality attribute for parenteral formulations. Typically, surfactant quantification is performed by mixed mode chromatography with evaporative light scattering detection (ELSD) or charged aerosol detection (CAD). However, these methods often suffer from loss of specificity in highly concentrated protein formulations. Here we present a mixed mode chromatography method using single quad mass detection, overcoming current limitations for highly concentrated proteins. In addition to content determination of intact surfactants, this method allows to quantify and characterize the predominant degradation patterns of polysorbates within a single measurement. Formulations with up to 200 mg/mL active pharmaceutical product (API) containing surfactant levels between 0.16 and 0.64 mg/mL were tested during method qualification. The obtained results for linearity (r > 0.99), precision (max. 3.8 % RSD) and accuracy (96-116 % recovery) meet current requirements for pharmaceutical products as defined in ICH Q2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Surface-Active AgentsBiological ProductsPolysorbatesChemistry, PharmaceuticalPoloxamer

Stichwörter der Autor:innen

Biotherapeutic formulationContent determinationMethod developmentMethod qualificationSingle quad MS detectorSurfactant

Substanzen

Surface-Active AgentsPolysorbatesBiological ProductsPoloxamer

Autor:innen und Institutionen

  • F. Hoffmann-La Roche AG, Grenzacherstrasse 24, CH-4070 Basel, Switzerland. Electronic address: robert.kopf@roche.com.
  • F. Hoffmann-La Roche AG, Grenzacherstrasse 24, CH-4070 Basel, Switzerland.

Förderung

  • Kite Pharma

Zitieren

APA

Kopf, R., Paschen, C., Müller, L., Kocar, B., Wolfring, M., Vincent, M., Klemm, D., Bell, C., & Pinto, C. (2023). Leveraging mass detection to simultaneously quantify surfactant content and degradation mode for highly concentrated biopharmaceuticals. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2023.115651

Vancouver

Kopf R, Paschen C, Müller L, Kocar B, Wolfring M, Vincent M, et al. Leveraging mass detection to simultaneously quantify surfactant content and degradation mode for highly concentrated biopharmaceuticals. Journal of Pharmaceutical and Biomedical Analysis. 2023. doi:10.1016/j.jpba.2023.115651

BibTeX
@article{Kopf2023,
  author = {Kopf, Robert and Paschen, Christoph and Müller, Lavinia and Kocar, Berk and Wolfring, Martin and Vincent, Mathilde and Klemm, Denis and Bell, Christian and Pinto, Cosimo},
  title = {Leveraging mass detection to simultaneously quantify surfactant content and degradation mode for highly concentrated biopharmaceuticals},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2023},
  doi = {10.1016/j.jpba.2023.115651}
}
Kostenlos starten →